Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Specjalistyczny Gabinet Diabetologiczny Radoslaw Rumianowski

Research site

Poland Szarych Szeregow 38/III/1, 66-400 Gorzów Wielkopolski, Poland

  • 1 trial recruiting
  • Type 2 diabetes mellitus · Arteriosclerosis · Chronic kidney disease
  • Adult patients

About Specializations

Specjalistyczny Gabinet Diabetologiczny Radoslaw Rumianowski in Gorzów Wielkopolski, Poland specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Arteriosclerosis, Chronic kidney disease, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Endocrinology and Metabolic Disorders

The medical center is at the forefront of research in endocrinology, focusing on innovative treatments for metabolic disorders such as Type 2 Diabetes. The center's research aims to enhance glycaemic control through novel therapeutic approaches.

  • Insulin Therapy Innovations
  • Combination Therapies
  • Metabolic Regulation

By exploring the synergistic effects of insulin icodec and semaglutide, the center contributes to the development of advanced treatment protocols that aim to improve patient outcomes in managing Type 2 Diabetes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Szarych Szeregow 38/III/166-400 Gorzów WielkopolskiPoland
Open in maps ↗
Recruiting now
1 trial
Conditions studied
5

More sites in Gorzów WielkopolskiPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Type 2 diabetes mellitus+2

Recruiting

Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus

Not recruiting

Study comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus

Not recruiting

Study on How Insulin Icodec and Semaglutide Help Control Blood Sugar in Patients with Type 2 Diabetes

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Icodec
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.